The role of endothelial cell reactive antibodies in peripheral vascular disease

Autoimmunity Reviews

Volumn 3, Issue 2, 2004, Pages 39-44

  Armitage, J D ^a   Homer Vanniasinkam, S ^a   Lindsey, N J ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Endothelial cells; Ischaemia; Peripheral vascular disease

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; HEAT SHOCK PROTEIN;

ENDOTHELIUM CELL; HUMAN; ISCHEMIA; NONHUMAN; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; REVIEW; RISK ASSESSMENT;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ARTERIOSCLEROSIS; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; ENDOTHELIUM, VASCULAR; GLYCOPROTEINS; HEAT-SHOCK PROTEINS; HUMANS; PERIPHERAL VASCULAR DISEASES;

EID: 1442348267     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(03)00087-9     Document Type: Review

References (40)

1. Fowkes F.G., Housley E., Cawood E.H., Macintyre C.C., Ruckley C.V., Prescott R.J. Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 20:(2):1991;384-392.
2. Dormandy J., Heeck L., Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg. 12:(2):1999;123-137.
3. Dormandy J., Belcher G., Broos P., et al. Prospective study of 713 below-knee amputations for ischaemia and the effect of a prostacyclin analogue on healing. Hawaii Study Group. Br J Surg. 81:(1):1994;33-37.
4. Dormandy J., Heeck L., Vig S. Predictors of early disease in the lower limbs. Semin Vasc Surg. 12:(2):1999;109-117.
5. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:(2):1999;115-126.
6. Shoenfeld Y., Harats D., George J. Atherosclerosis and the antiphospholipid syndrome: a link unravelled? Lupus. 7:(Suppl 2):1998;S140-S143.
7. Lindqvist K.J., Osterland C.K. Human antibodies to vascular endothelium. Clin Exp Immunol. 9:1971;753-760.
8. Del Papa N., Guidali L., Sala A., et al. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum. 40:(3):1997;551-561.
9. Chan T.M., Yu P.M., Tsang K.L., Cheng I.K. Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations. Clin Exp Immunol. 100:(3):1995;506-513.
10. Yazici Z.A., Raschi E., Patel A., et al. Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro. Int Immunol. 13:(3):2001;349-357.
11. Johnson P.A., Alexander H.D., McMillan S.A., Maxwell A.P. Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis. Clin Exp Immunol. 108:(2):1997;234-242.
12. Schett G., Xu Q., Amberger A., et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest. 96:(6):1995;2569- 2577.
13. Mayr M., Metzler B., Kiechl S., et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation. 99:(12):1999;1560-1566.
14. Derksen R.H., Kater L. Lupus anticoagulant: revival of an old phenomenon. Clin Exp Rheumatol. 3:(4):1985;349-357.
15. McNeil H.P., Simpson R.J., Chesterman C.N., Krilis S.A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA. 87:(11):1990;4120-4124.
16. George J., Shoenfeld Y. The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. Lupus. 6:(7):1997;559-560.
17. Vaarala O., Manttari M., Manninen V., et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation. 91:(1):1995;23-27.
18. Farsi A., Domeneghetti M.P., Fedi S., et al. High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart disease. Autoimmunity. 30:(2):1999;93-98.
19. Tanne D., Triplett D.A., Levine S.R. Antiphospholipid-protein antibodies and ischemic stroke: not just cardiolipin any more. Stroke. 29:(9):1998;1755- 1758.
20. Fiallo P., Tomasina C., Clapasson A., Cardo P.P. Antibodies to beta(2)-glycoprotein I in ischemic stroke. Cerebrovasc Dis. 10:(4):2000;293-297.
21. Phadke K.V., Phillips R.A., Clarke D.T., Jones M., Naish P., Carson P. Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br Heart J. 69:(5):1993;391-394.
22. Sletnes K.E., Smith P., Abdelnoor M., Arnesen H., Wisloff F. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet. 339:(AB(8791)):1992;451-453.
23. Del Papa N., Guidali L., Spatola L., et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol. 13:(2):1995;179-185.
24. George J., Blank M., Levy Y., et al. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation. 1998;900-906.
25. Riboldi P., Gerosa M., Raschi E., Testoni C., Meroni P.L. Endothelium as a target for antiphospholipid antibodies. Immunobiology. 207:(1):2003;29-36.
26. Shoenfeld Y., Sherer Y., George J., Harats D. Autoantibodies associated with atherosclerosis. Ann Med. 32:(Suppl 1):2000;37-40.
27. George J., Harats D., Gilburd B., et al. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation. 102:(15):2000;1822-1827.
28. George J., Afek A., Gilburd B., Shoenfeld Y., Harats D. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J Am Coll Cardiol. 38:(3):2001;900-905.
29. Johnson A.D., Berberian P.A., Tytell M., Bond M.G. Differential distribution of 70-kD heat shock protein in atherosclerosis. Its potential role in arterial SMC survival. Arterioscler Thromb Vasc Biol. 15:(1):1995;27-36.
30. Kleindienst R., Xu Q., Willeit J., Waldenberger F.R., Weimann S., Wick G. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol. 142:(6):1993;1927-1937.
31. Williams R.S. Heat shock protein 47: a chaperone for the fibrous cap? Circulation. 101:(11):2000;1227-1228.
32. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol. 22:(10):2002;1547-1559.
33. Zhu J., Quyyumi A.A., Rott D., et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation. 103:(8):2001;1071-1075.
34. Wright B.H., Corton J.M., El Nahas A.M., Wood R.F., Pockley A.G. Elevated levels of circulating heat shock protein 70 (Hsp70) in peripheral and renal vascular disease. Heart Vessels. 15:(1):2000;18-22.
35. Chan Y.C., Shukla N., Abdus-Samee M., et al. Anti-heat-shock protein 70 kDa antibodies in vascular patients. Eur J Vasc Endovasc Surg. 18:(5):1999;381-385.
36. Xu Q., Dietrich H., Steiner H.J., et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb. 12:(7):1992;789-799.
37. George J., Shoenfeld Y., Afek A., et al. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol. 19:(3):1999;505-510.
38. Chan T.M., Frampton G., Cameron J.S. Identification of DNA-binding proteins on human umbilical vein endothelial cell plasma membrane. Clin Exp Immunol. 91:(1):1993;110-114.
39. Mayet W.J., Meyer zum Buschenfelde K.H. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol. 94:(3):1993;440-446.
40. Farsi A., Domeneghetti M.P., Brunelli T., et al. Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies. Atherosclerosis. 154:(2):2001;429-436.